This patent teaches the generation of islet like cells from pancreatic stem cells. It is useful for the treatment of diabetes. One source of stem cells used in this patent is pancreatic duct stem cells.
This is basically the patent that covers how to generate neurons from embryonic stem cells. Of course the various composition of matter patents on embryonic stem cells (5,843,780, 6,200,806, 7,029,913) have to be in-licensed to use this invention. The invention has one broad independent claim which covers a method of differentiating human embryonic stem cells into neurons. The method...
One of the potential problems with stem cell therapy is the propensity of certain cell types to contribute to scar formation. For example, during embryonic healing, scars are not formed on injured tissues, however, adult injured tissue is prone to scarring. Formation of scars is especially relevant in the post-myocardial infarct situation in which the non-functional scar tissue replaces...
Hedgehog proteins are involved in development and other biological functions through activation of their receptor called "patched". Hedgehog signalling is inhibited by cyclopamine. Since the authors of the patent originally found that inhibiting hedgehog signalling reduces insulin production, and transfection with hedgehog increases insulin production, (Thomas
This patent teaches the generation of human hematopoietic stem cells from human embryonic stem cells by the simple culture of the embryonic stem cells on human bone amrrow stromal cells.
Generation and expansion of neuronal cells is described in this patent through inducting proliferation of GFAP+, nestin+ stem cells of neuronal origin through treatment with EGF, amphiregulin, aFGF, bFGF, TGF.alpha. and then inducing differentiation through serum free culture. The cells generated by this means...
This patent has some pretty broad claims. It teaches to repair tissue by inducing de-differentiation of cells, and then stimulating redifferentiation into another histological cell type. This patent may be very strong ammunition against companies active in the area of stem cell therapy that have not licensed it.
This patent seems to cover a composition of cells that is made of adipose tissue and hematopoietic tissue. The composition is useful for regeneration of a hematopoietic system after ablation. Additionally, this composition may have uses for the induction of angiogenesis. In some papers, the induction of angiogenesis by bone marrow stem cells requires large amounts of stem cells to be...
This patent teaches that administration of prolactin may be used for enhancing hematopoiesis. This is interesting since there are other patents, including by Stem Cell Therapeutics, that teach the use of prolactin and other compounds for stimulation of neural stem cells.
This patent teaches ways of dedifferentiating pancreatic duct or exocrine cells and then redifferentiating the cells to generate functional islet cells. This patent is especially relevant in light of the Edmonton Protocol that provides methods of transplanting allogeneic pancreatic islets. The problem with the Edmonton Protocol is that it takes up to 2, sometimes even more pancreas's for 1...